SM
Skybound Medtech Inc.
SEC filingBiotechnology · Houston, TX
Amount raised$1.3Msold at filing
Total offering$1.3M
Investors in the raise5count reported to the SEC
FiledJul 9, 2026first sale Jun 8, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Matthew KuhnExecutive Officer
Executive officers, directors and promoters as listed on the Form D.